Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 07:47:55 28/02/2017 +03 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.66M 2.45M 2.3M 4.31M 293M 4.37M 29.07M 11.29M 142M 11.56M 11.31M 493M P/E Ratio 2017
-6.41x
P/E Ratio 2018 -3.16x
Enterprise Value 3.63M 3.14M 2.89M 2.71M 5.07M 345M 5.15M 34.24M 13.3M 168M 13.62M 13.33M 581M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
-0.35%-0.22%-15.03%-12.88% 42.96B
+3.11%-1.17%+277.22%+502.47% 31.73B
+0.22%-2.90%+14.25%-12.16% 30.22B
+1.62%-5.52%+0.79%+22.42% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-1.63%+1.89%+54.59%+124.83% 13.57B
-0.40%-1.48%+7.48%+7.12% 12.96B
+1.14%-0.36% - - 13.39B
-0.74%-2.47%+102.47%+80.26% 12.2B
Average +10.71%+9.36%+56.72%+91.18% 20.98B
Weighted average by Cap. +1.02%-1.08%+55.88%+95.96%

Financials

2017 2018
Net sales 16.01K 13.84K 12.75K 11.94K 22.39K 1.52M 22.73K 151K 58.7K 740K 60.08K 58.8K 2.56M 124 107.2 98.75 92.5 173.44 11.79K 176.06 1.17K 454.61 5.73K 465.35 455.43 19.86K
Net income -481K -416K -383K -359K -673K -45.74M -683K -4.54M -1.76M -22.24M -1.8M -1.77M -77.04M -976K -843K -777K -728K -1.36M -92.78M -1.39M -9.21M -3.58M -45.11M -3.66M -3.58M -156M
Net Debt 497K 429K 396K 371K 695K 47.24M 705K 4.69M 1.82M 22.97M 1.86M 1.82M 79.57M 548K 474K 437K 409K 767K 52.15M 779K 5.17M 2.01M 25.35M 2.06M 2.01M 87.83M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!